Display options
Cite
Thomas MT, Shah S, Popat H, et al. Hypoglycaemia and myotonic dystrophy. J Paediatr Child Health. 2021;doi: 10.1111/jpc.15633.
Thomas, M. T., Shah, S., Popat, H., Hanna, B., & Jani, P. (2021). Hypoglycaemia and myotonic dystrophy. Journal of paediatrics and child health, . https://doi.org/10.1111/jpc.15633
Thomas, Meryl T, et al. "Hypoglycaemia and myotonic dystrophy." Journal of paediatrics and child health vol. (2021). doi: https://doi.org/10.1111/jpc.15633
Thomas MT, Shah S, Popat H, Hanna B, Jani P. Hypoglycaemia and myotonic dystrophy. J Paediatr Child Health. 2021 Jun 29; doi: 10.1111/jpc.15633. Epub 2021 Jun 29. PMID: 34184806.
Copy Download .nbib Format: NLM
Share it on

J Paediatr Child Health. 2021 Jun 29; doi: 10.1111/jpc.15633. Epub 2021 Jun 29.

Hypoglycaemia and myotonic dystrophy.

Journal of paediatrics and child health

Meryl T Thomas, Swapnil Shah, Himanshu Popat, Bernadette Hanna, Pranav Jani

Affiliations

  1. Neonatal Intensive Care Unit, Westmead Hospital, Sydney, New South Wales, Australia.
  2. Neonatal intensive care unit, Westmead Hospital, Sydney, New South Wales, Australia.
  3. Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  4. Grace Centre for Newborn Care, The Children's Hospital Westmead, Sydney, New South Wales, Australia.
  5. Clinical Genetics, The Children's Hospital Westmead, Sydney, New South Wales, Australia.

PMID: 34184806 DOI: 10.1111/jpc.15633

[No abstract available.]

References

  1. Thornton CA. Myotonic dystrophy. Neurol. Clin. 2014; 32: 705-19. - PubMed
  2. Ho G, Cardamone M, Farrar M. Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions. World J. Clin. Pediatr. 2015; 4: 66-80. - PubMed
  3. Kallem VR, Pandita A, Gupta G. Hypoglycemia: When to treat? Clin. Med. Insights Pediatr. 2017; 11: 1179556517748913. - PubMed
  4. Ellahony D, El-Mekkawy M, A. Issa A. Prevalence of glucose level abnormalities in neonatal sepsis and its association with mortality. Menoufia Med. J. 2020; 33: 127-31. - PubMed
  5. Dahlqvist JR, Vissing J. Diabetes in Myotonic Dystrophy. In Barbetti F, Ghizzoni L, Guaraldi F, editors, Diabetes Associated with Single Gene Defects and Chromosomal Abnormalities. Basel, Switzerland: Karger; 2017. p. 182-187. - PubMed
  6. Renna LV, Bosè F, Iachettini S et al. Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle. PLoS One 2017; 12: e0184987. - PubMed
  7. Kasagi S, Shiota M, Ando M, Takeshita K. Hyperinsulinism in congenital myotonic dystrophy. No To Hattatsu 1989; 21: 585-7. - PubMed
  8. Sweet CB, Grayson S, Polak M. Management strategies for neonatal hypoglycemia. J. Pediatr. Pharmacol. Ther. 2013; 18: 199-208. - PubMed
  9. Edwards T, Harding JE. Clinical aspects of neonatal hypoglycemia: A mini review. Front. Pediatr. 2021; 8: 562251. - PubMed
  10. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 1988; 297: 1304-8. - PubMed

Publication Types